As the massive international 1000 Genome project winds to a close in its efforts to define personal genomes, Yale researchers illustrate the importance of maternal and paternal contributions to an ...

The notion of privacy and confidentiality of health information has a long and storied history. In the USA, there were several key incidents and policy developments in the second half of the 20th ...

BALTIMORE, Md.--(BUSINESS WIRE)--Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced the close of a $103 million Series C financing. The financing was led by Cowen ...

Use BBC.com or the new BBC App to listen to BBC podcasts, Radio 4 and the World Service outside the UK.

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN), an American biotechnology company, on Monday announced that it planned to acquire 23andMe Holding Co.'s Personal Genome Service, Total Health and ...

Would you want to know the secrets of your own genome, perhaps discovering that you are at risk for a disease like Alzheimer’s, for which there is no cure? If you did find out what lies in your genes, ...

A bankruptcy judge approved the sale of genetics company 23andMe to a non-profit led by co-founder and former CEO Anne Wojcicki, according to a June 27 filing in the bankruptcy docket. TTAM Research ...

NEW YORK (WRGB) — Regeneron Pharmaceuticals, Inc., the New York-based company, announced it has emerged as the successful bidder in the bankruptcy auction for nearly all assets of 23andMe Holding Co., ...

Participant privacy and confidentiality considerations are mainstays of human subjects research involving genetics and genomics. Perhaps the most salient illustration of this can be found in the ...